Vanguard Group’s FibroGen FGEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $944K | Sell |
|
|||||
|
2025
Q1 | $1.82M | Sell |
|
|||||
|
2024
Q4 | $3.11M | Sell |
|
|||||
|
2024
Q3 | $2.35M | Sell |
|
|||||
|
2024
Q2 | $5.25M | Sell |
|
|||||
|
2024
Q1 | $15.1M | Sell |
|
|||||
|
2023
Q4 | $6.24M | Sell |
|
|||||
|
2023
Q3 | $7.82M | Sell |
|
|||||
|
2023
Q2 | $26.3M | Buy |
|
|||||
|
2023
Q1 | $165M | Sell |
|
|||||
|
2022
Q4 | $151M | Sell |
|
|||||
|
2022
Q3 | $127M | Buy |
|
|||||
|
2022
Q2 | $102M | Buy |
|
|||||
|
2022
Q1 | $112M | Buy |
|
|||||
|
2021
Q4 | $127M | Buy |
|
|||||
|
2021
Q3 | $85.1M | Buy |
|
|||||
|
2021
Q2 | $210M | Buy |
|
|||||
|
2021
Q1 | $270M | Buy |
|
|||||
|
2020
Q4 | $281M | Buy |
|
|||||
|
2020
Q3 | $303M | Sell |
|
|||||
|
2020
Q2 | $306M | Buy |
|
|||||
|
2020
Q1 | $248M | Buy |
|
|||||
|
2019
Q4 | $301M | Sell |
|
|||||
|
2019
Q3 | $270M | Buy |
|
|||||
|
2019
Q2 | $329M | Buy |
|
|||||
|
2019
Q1 | $392M | Buy |
|
|||||
|
2018
Q4 | $331M | Buy |
|
|||||
|
2018
Q3 | $421M | Buy |
|
|||||
|
2018
Q2 | $425M | Buy |
|
|||||
|
2018
Q1 | $300M | Buy |
|
|||||
|
2017
Q4 | $289M | Sell |
|
|||||
|
2017
Q3 | $342M | Buy |
|
|||||
|
2017
Q2 | $188M | Buy |
|
|||||
|
2017
Q1 | $124M | Buy |
|
|||||
|
2016
Q4 | $99.6M | Buy |
|
|||||
|
2016
Q3 | $93.4M | Buy |
|
|||||
|
2016
Q2 | $69.3M | Buy |
|
|||||
|
2016
Q1 | $82.6M | Buy |
|
|||||
|
2015
Q4 | $109M | Buy |
|
|||||
|
2015
Q3 | $75.1M | Buy |
|
|||||
|
2015
Q2 | $58M | Buy |
|
|||||
|
2015
Q1 | $15.1M | Buy |
|
|||||
|
2014
Q4 | $409K | Buy |
|